These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21878191)

  • 1. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.
    Gheorghiade M; Ambrosy AP; Ferrandi M; Ferrari P
    Discov Med; 2011 Aug; 12(63):141-51. PubMed ID: 21878191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
    Micheletti R; Palazzo F; Barassi P; Giacalone G; Ferrandi M; Schiavone A; Moro B; Parodi O; Ferrari P; Bianchi G
    Am J Cardiol; 2007 Jan; 99(2A):24A-32A. PubMed ID: 17239701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.
    Ferrari P; Micheletti R; Valentini G; Bianchi G
    Med Hypotheses; 2007; 68(5):1120-5. PubMed ID: 17113239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
    Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P
    Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving cardiac Ca⁺² transport into the sarcoplasmic reticulum in heart failure: lessons from the ubiquitous SERCA2b Ca⁺² pump.
    Vangheluwe P; Wuytack F
    Biochem Soc Trans; 2011 Jun; 39(3):781-7. PubMed ID: 21599649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].
    Rocchetti M; Besana A; Mostacciuolo G; Micheletti R; Ferrari P; Sarkozi S; Szegedi C; Jona I; Zaza A
    J Pharmacol Exp Ther; 2005 Apr; 313(1):207-15. PubMed ID: 15576469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
    Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
    Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
    Shah SJ; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Grzybowski J; Valentini G; Sabbah HN; Gheorghiade M;
    Am Heart J; 2009 Jun; 157(6):1035-41. PubMed ID: 19464414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failure.
    Wehrens XH
    Curr Opin Investig Drugs; 2007 Sep; 8(9):769-77. PubMed ID: 17729189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.
    Arici M; Ferrandi M; Barassi P; Hsu SC; Torre E; Luraghi A; Ronchi C; Chang GJ; Peri F; Ferrari P; Bianchi G; Rocchetti M; Zaza A
    J Pharmacol Exp Ther; 2023 Jan; 384(1):231-244. PubMed ID: 36153005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
    Khan H; Metra M; Blair JE; Vogel M; Harinstein ME; Filippatos GS; Sabbah HN; Porchet H; Valentini G; Gheorghiade M
    Heart Fail Rev; 2009 Dec; 14(4):277-87. PubMed ID: 19238540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
    Blair JE; Macarie C; Ruzyllo W; Bacchieri A; Valentini G; Bianchetti M; Pang PS; Harinstein ME; Sabbah HN; Filippatos GS; Gheorghiade M;
    Am J Ther; 2008; 15(3):231-40. PubMed ID: 18496261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
    Gheorghiade M; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Valentini G; Sabbah HN;
    J Am Coll Cardiol; 2008 Jun; 51(23):2276-85. PubMed ID: 18534276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications.
    Huang CL
    Br J Pharmacol; 2013 Oct; 170(3):486-8. PubMed ID: 23822610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Istaroxime: a new luso-inotropic agent for heart failure.
    Mattera GG; Lo Giudice P; Loi FM; Vanoli E; Gagnol JP; Borsini F; Carminati P
    Am J Cardiol; 2007 Jan; 99(2A):33A-40A. PubMed ID: 17239702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a minipig model of chronic ischemic heart failure].
    Xin W; Lu XC; Li XY; Niu K; Cai JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):336-42. PubMed ID: 21624310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure].
    Fu ZQ; Li XY; Liu XH; Sun S; Liu T; Mi YF; Zhou SA; Ye WH; Wang QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):260-5. PubMed ID: 19099986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.
    Maier LS; Wahl-Schott C; Horn W; Weichert S; Pagel C; Wagner S; Dybkova N; Müller OJ; Näbauer M; Franz WM; Pieske B
    Cardiovasc Res; 2005 Sep; 67(4):636-46. PubMed ID: 15932750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.